Dermatology and COVID-19 in the Outpatient Setting: What Clinicians Need to Know

By clicking the continue button above, I certify I have read the CME/CPE/MOC statements below.



Release Date: December 18, 2020
Expiration Date: December 18, 2021


PROGRAM DESCRIPTION
Patients with inflammatory skin conditions like atopic dermatitis and psoriasis are at greater risk for infection or complications from COVID-19 due to their high-risk comorbidities and use of immunosuppressive medications. These patients require specialized care during this time to reduce their risk of exposure and infection.

This activity, “Dermatology and COVID-19 in the Outpatient Setting: What Clinicians Need to Know” will provide dermatology clinicians with the most up-to-date guidance on managing patients with inflammatory skin conditions during the current pandemic, including information on the pathophysiology of Sars-Cov-2, the risk of infection in these patients, and strategies to manage patient care and counsel through telemedicine.

AGENDA
Welcome and introductions
Understanding the Pathophysiology of COVID-19
Recognizing Clinical and Patient Features that Increase Risk of COVID-19 Infection and Associated Complications in Patients with Inflammatory Skin Conditions
Recommendations for Managing Dermatology Patients in the COVID-19 Pandemic
Q&A session

PROGRAM FACULTY

 Steven R. Feldman, MD, PhD
 Professor of Dermatology, Pathology, and Social Sciences & Health Policy
 Wake Forest School of Medicine
 Winston-Salem, NC





Steven R. Feldman, MD, PhD is Professor of Dermatology, Pathology, Social Sciences & Health Policy, and Molecular Medicine & Translational Science at the Wake Forest School of Medicine. He serves on the Medical Board of the National Psoriasis Foundation and directed psoriasis education programs for the American Academy of Dermatology. According to Expertscape.com, Feldman was the #1 expert in the world on psoriasis. He has published over 1,000 Medline-referenced articles and is the co-author of the book, WHEN WILL IT EVER GO AWAY: PRACTICAL ANSWERS TO YOUR COVID-19 QUESTIONS.

 J. Morgan Freiman, MD, MSc
 Infectious Diseases Physician
 Director of Antimicrobial Stewardship
 Lahey Hospital and Medical Center
 Assistant Professor of Medicine
 Tufts University School of Medicine
 Boston, MA

J. Morgan Freiman, MD, MSc is an Infectious Diseases physician and the Director for the Antimicrobial Stewardship Program at Lahey Hospital and Medical Center in Burlington, MA. She trained in infectious diseases and epidemiology at Boston Medical Center and Boston University School of Public Health, prior to joining the faculty at Tufts Medical School. She worked on the front lines during the COVID-19 pandemic providing care for hundreds of patients and lead a multi-disciplinary committee to create and implement treatment guidelines for her home institution.

 Steven A. Scott, PharmD
 Associate Professor
 Department of Pharmacy Practice
 Perdue University College of Pharmacy
 West Lafayette, IN




Steven A. Scott PharmD is an Associate Professor of Pharmacy Practice and Director of Alumni Engagement in the Department of Pharmacy Practice at the Purdue University College of Pharmacy. He received his BS in pharmacy and doctor of pharmacy degrees from Purdue University in 1976 and 1978, respectively, and then completed a hospital pharmacy residency at St. Lawrence Hospital in Lansing, Michigan. Dr. Scott’s first academic appointment was at the University of Houston and he then assumed an affiliate clinical faculty role at Riley Children’s Hospital in Indianapolis in 1980. Following seven years of clinical practice in pediatrics, he moved to the main Purdue campus in West Lafayette where he has practiced in both internal medicine and long-term care settings. Current teaching and scholarly interests include dermatologic therapeutics, men’s health issues, population health, programmatic and individual student assessment, and enhancing leadership development in students. Dr. Scott routinely serves as a preceptor for students on both his academic and leadership APPE rotations where he focuses on passing along both wisdom and knowledge. In addition to his current role as chair of the Orientation Steering Committee, Dr. Scott has previously served on the college’s Curriculum, Admissions, and Assessment Committees. His scholarship currently focuses in the areas of dermatologic therapeutics, student and leadership development, and pharmacy education.

Dr. Scott has been a member of the American Association of Colleges of Pharmacy (AACP) since 1985. Dr. Scott was elected to the AACP Board of Directors (2013-2016) and to serve as chair of the Council of Faculties (2014-2015) and was elected to another 3-year term on the Board of Directors and serving as AACP President in 2017-18. He currently serves on AACP’s Argus Commission and the Leadership Development Task Force. In addition to his involvement with AACP, Dr. Scott currently serves on the Executive Committee of the American Foundation for Pharmaceutical Education, and has been a long term member of the American Society of Health-System Pharmacists, serving as the ASHP faculty liaison for the college. He currently serves as faculty advisor the Purdue University-Alpha Zeta Chapter of the Rho Chi Honor Society.

Dr. Scott has been married for 42 years to his wife, Cathy. Together they have two adult children and four grandchildren. In his leisure time, Dr. Scott enjoys traveling to quiet and relaxing locations, following Purdue sports, attending his grandchildren’s events and activities, pursuing his love for history through reading, and keeping in touch with hundreds of his former students

TARGET AUDIENCE
The intended audience for this educational initiative is dermatologists and other clinicians who treat patients with inflammatory skin conditions. This enduring webcourse will allow easy access to information essential to these healthcare providers nationwide.

EDUCATIONAL OBJECTIVES
The proposed initiative is designed to address ACGME and NAM competencies, including delivering patient-centered care and practicing evidence-based medicine.

This program is designed to address ACPE competencies, including foundational knowledge, and approach to practice and care 

At the conclusion of this education, participants should be able to:
  • Discuss the most current understanding of the pathophysiology of COVID-19
  • Recognize and evaluate factors that increase risk of COVID infection among patients with inflammatory skin conditions
  • Integrate recommendations for the safe and effective management of patients with inflammatory skin conditions during the COVID-19 pandemic
  • Provide counsel to dermatology patients regarding concerns or fears related to COVID-19

PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME/CPE/MOC credit or the evaluation, please email contact@potomacme.org.

ABIM MOC DESIGNATION STATEMENT
 Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
For ABIM MOC points, your information will be shared with the ABIM through PCME's ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

MOC APPROVAL STATEMENT
 Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice         relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, "Dermatology and COVID-19 in the Outpatient Setting: What Clinicians Need to Know" has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II CME Activity
Family Medicine

PHARMACIST ACCREDITATION STATEMENT
The Potomac Center for Medical Education is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



PHARMACIST CREDIT DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this educational activity for a maximum of 1.0 contact hour (0.10 CEUs) of continuing education credit (UAN number 0418-9999-20-011-H01-P).

This is an application-based activity.

DISCLOSURE INFORMATION
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

Program Faculty
The faculty, authors and content developers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Steven R. Feldman, MD, PhD: Consultant/Independent Contractor: AbbVie, Advance Medical, Alvotech, Almirall, Amgen, Arena, Bristol-Myers Squibb, Caremark, Celgene, Galderma Laboratories, L.P., Helsinn, Janssen, Kikaku, Leo Pharma Inc., Lilly, Merck & Co., Inc., Mylan, Novartis, Ortho Dermatology, Pfizer, Regeneron, Sanofi, Sienna, Suncare Research, Sun Pharma, Xenoport; Grant/Research Support: Abbvie, Amgen, Celgene, Galderma Laboratories, L.P., Janssen, Lilly, Novartis, Pfizer, Regeneron, Sanofi; Royalties: Informa; Speaker's Bureau: AbbVie, Amgen, Celgene, Janssen, Lilly, Leo Pharma Inc., Novartis, Ortho Dermatology, Pfizer, Regeneron, Sanofi, Sun Pharma

J. Morgan Freiman, MD, MSc: Nothing to disclose

Steven A. Scott PharmD: Nothing to disclose

Planners and Managers
The planners and mangers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:  

Chelsey Goins, PhD: Nothing to disclose

Content Reviewers
The content reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:

Lindsay Scott, PT, DPT, ATC: Nothing to disclose

FDA DISCLOSURE
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

HARDWARE/SOFTWARE REQUIREMENTS
Please ensure the computer system you plan to use meets the following minimum requirements:
  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac & Windows): Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher, & Opera 5 or higher
  • Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
  • Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

INSTRUCTIONS FOR PARTICIPANTS AND OBTAINING CME/CPE CREDIT AND MOC POINTS
There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME/CPE/MOC activity in its entirety, and then complete the post-test, with a score of 75% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.

Jointly provided by the Potomac Center for Medical Education and Rockpointe

 

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Click here for the PCME Privacy Policy
Facebook - RockPointe Twitter - RockPointe LinkedIn - RockPointe